Deals Of The Week: Vertex/GSK, Vertex/Janssen, Boehringer Ingelheim/Ensemble

Disparate events including Hurricane Sandy, extended-release generics, drug compounding and biopharma deal-making each highlighted just how important a challenge quality has become in the industry.

Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO Blog. Visit the blog at http://invivoblog.blogspot.com.

Lots of news this past week either directly or indirectly highlighted concerns about the quality of everything related to infrastructure,...

More from Archive

More from Pink Sheet